Related Experiment Video
Updated: Jul 4, 2026
07:45
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
[Benign thyroid nodules: diagnostic and therapeutic approach]
Cosimo Durante1, Francesco Cava, Alessandra Paciaroni
1II Clinica Medica, Dipartimento di Scienze Cliniche, Policlinico Umberto I, Università La Sapienza, Roma.
Recenti Progressi in Medicina
|June 28, 2008
Summary
Increased thyroid nodule detection, primarily benign, necessitates careful management. Fine-needle aspiration cytology guides treatment choices, balancing risks and benefits for patients.
Area of Science:
- Endocrinology
- Oncology
- Diagnostic Imaging
Context:
- Epidemiological studies show a rise in thyroid nodule detection.
- Routine diagnostic sonography contributes to increased detection rates.
- Thyroid nodules are rarely malignant, but accurate diagnosis is crucial.
Purpose:
- To review the diagnostic and therapeutic strategies for thyroid nodules.
- To emphasize the role of fine-needle aspiration cytology (FNAc) in nodule characterization.
- To discuss management options for benign thyroid nodules.
Summary:
- Fine-needle aspiration cytology (FNAc) is central to determining if thyroid nodules are malignant or benign.
- Benign nodules have various management options, including observation, iodine supplementation, hormone therapy, radioiodine, ethanol injections, and laser photocoagulation.
- Treatment decisions for benign thyroid nodules require a thorough risk-benefit analysis tailored to the individual patient.
Impact:
- Improved diagnostic accuracy for thyroid nodules.
- Informed clinical decision-making for benign thyroid nodule management.
- Optimized patient care by selecting appropriate therapeutic strategies based on individual needs.
Related Concept Videos
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...